zidovudine has been researched along with Erythema in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fotiades, J; Jiang, SB; Lim, HW; Moy, J; Sanchez, M; Soter, NA | 1 |
| Acosta, EP; Henry, K; Jochimsen, E | 1 |
| Basgoz, N; D'Aquila, RT; Fischl, MA; Hirsch, MS; Hughes, MD; Johnson, VA; Liou, SH; Myers, M; Niu, M; Sommadossi, JP; Timpone, J | 1 |
| Davey, RT; Davey, VJ; Falloon, J; Kovacs, JA; Lane, HC; Masur, H; Metcalf, JA; Polis, MA; Zunich, KM; Zurlo, JJ | 1 |
2 trial(s) available for zidovudine and Erythema
| Article | Year |
|---|---|
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protoco
Topics: Adult; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Erythema; Female; HIV Infections; HIV-1; Humans; Male; Nevirapine; Prospective Studies; Pyridines; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 1996 |
A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
Topics: Administration, Oral; Adult; CD4-Positive T-Lymphocytes; Drug Evaluation; Drug Therapy, Combination; Erythema; Follow-Up Studies; Gene Products, gag; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Antigens; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Male; Neutropenia; Recombinant Proteins; Sarcoma, Kaposi; Viral Core Proteins; Zidovudine | 1991 |
3 other study(ies) available for zidovudine and Erythema
| Article | Year |
|---|---|
Efficacy of ultraviolet B phototherapy for psoriasis in patients infected with human immunodeficiency virus.
Topics: Administration, Cutaneous; Adult; Antiviral Agents; Body Surface Area; Case-Control Studies; CD4 Lymphocyte Count; Dermatitis, Exfoliative; Erythema; HIV Infections; HIV Seronegativity; Humans; Immunocompromised Host; Keratolytic Agents; Male; Psoriasis; Salicylates; Salicylic Acid; Ultraviolet Rays; Ultraviolet Therapy; Zidovudine | 1995 |
Hepatotoxicity and rash associated with zidovudine and zalcitabine chemoprophylaxis.
Topics: Chemical and Drug Induced Liver Injury; Erythema; Female; HIV Infections; Humans; Middle Aged; Zalcitabine; Zidovudine | 1996 |
Nevirapine triple combo results released.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; Erythema; HIV Infections; HIV-1; Humans; Nevirapine; Pyridines; Virus Replication; Zidovudine | 1995 |